Literature DB >> 16618111

Invariant chain transmembrane domain trimerization: a step in MHC class II assembly.

Ann M Dixon1, Bradford J Stanley, Erin E Matthews, Jessica P Dawson, Donald M Engelman.   

Abstract

The transmembrane (TM) domain of the major histocompatibility complex (MHC) class II-associated invariant chain (Ii) has long been implicated in both correct folding and function of the MHC class II complex. To function correctly, Ii must form a trimer, and the TM domain is one of the domains thought to stabilize the trimeric state. Specific mutations in the TM domain have been shown previously to disrupt MHC class II functions such as mature complex formation and antigen presentation, possibly due to disruption of Ii TM helix-helix interactions. Although this hypothesis has been reported several times in the literature, thus far no experimental measurements have been made to explore the relationship between TM domain structure and TM mutations that affect Ii function. We have applied biophysical and computational methods to study the folding and assembly of the Ii TM domain in isolation and find that the TM domain strongly self-associates. According to analytical ultracentrifugation analyses, the primary oligomeric state for this TM domain is a strongly associated trimer with a dissociation constant of approximately 120 nM in DPC micelles. We have also examined the effect of functionally important mutations of glutamine and threonine residues in the TM domain on its structure, providing results that now link the disruption of TM helix interactions to previously reported losses of Ii function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16618111     DOI: 10.1021/bi052112e

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  22 in total

1.  Invariant chain modulates HLA class II protein recycling and peptide presentation in nonprofessional antigen presenting cells.

Authors:  Azizul Haque; Laela M Hajiaghamohseni; Ping Li; Katherine Toomy; Janice S Blum
Journal:  Cell Immunol       Date:  2007-12-11       Impact factor: 4.868

Review 2.  Interaction and conformational dynamics of membrane-spanning protein helices.

Authors:  Dieter Langosch; Isaiah T Arkin
Journal:  Protein Sci       Date:  2009-07       Impact factor: 6.725

Review 3.  Ancient features of the MHC class II presentation pathway, and a model for the possible origin of MHC molecules.

Authors:  Johannes M Dijkstra; Takuya Yamaguchi
Journal:  Immunogenetics       Date:  2018-10-30       Impact factor: 2.846

4.  The transmembrane domain of the adenovirus E3/19K protein acts as an endoplasmic reticulum retention signal and contributes to intracellular sequestration of major histocompatibility complex class I molecules.

Authors:  Martina Sester; Zsolt Ruszics; Emma Mackley; Hans-Gerhard Burgert
Journal:  J Virol       Date:  2013-03-20       Impact factor: 5.103

5.  A novel regulatory pathway for autoimmune disease: binding of partial MHC class II constructs to monocytes reduces CD74 expression and induces both specific and bystander T-cell tolerance.

Authors:  Arthur A Vandenbark; Roberto Meza-Romero; Gil Benedek; Shayne Andrew; Jianya Huan; Yuan K Chou; Abigail C Buenafe; Rony Dahan; Yoram Reiter; Jeffery L Mooney; Halina Offner; Gregory G Burrows
Journal:  J Autoimmun       Date:  2012-09-29       Impact factor: 7.094

6.  Multi-Tox: application of the ToxR-transcriptional reporter assay to the study of multi-pass protein transmembrane domain oligomerization.

Authors:  Catherine Joce; Alyssa A Wiener; Hang Yin
Journal:  Biochim Biophys Acta       Date:  2011-07-23

7.  A transmembrane domain and GxxxG motifs within L2 are essential for papillomavirus infection.

Authors:  Matthew P Bronnimann; Janice A Chapman; Chad K Park; Samuel K Campos
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

8.  Gamma-IFN-inducible-lysosomal thiol reductase modulates acidic proteases and HLA class II antigen processing in melanoma.

Authors:  Oliver G Goldstein; Laela M Hajiaghamohseni; Shereen Amria; Kumaran Sundaram; Sakamuri V Reddy; Azizul Haque
Journal:  Cancer Immunol Immunother       Date:  2008-03-15       Impact factor: 6.968

9.  In vitro dimerization of the bovine papillomavirus E5 protein transmembrane domain.

Authors:  Joanne Oates; Matthew Hicks; Timothy R Dafforn; Daniel DiMaio; Ann M Dixon
Journal:  Biochemistry       Date:  2008-08-02       Impact factor: 3.162

10.  Screening for transmembrane association in divisome proteins using TOXGREEN, a high-throughput variant of the TOXCAT assay.

Authors:  Claire R Armstrong; Alessandro Senes
Journal:  Biochim Biophys Acta       Date:  2016-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.